Cite
MLA Citation
D. Planchard et al.. “LBA51Phase 2 trial (BRF113928) of dabrafenib (D) plus trametinib (T) in patients (pts) with previously untreated BRAF V600E–mutant metastatic non-small cell lung cancer (NSCLC).” Annals of oncology, vol. 28, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100097084058.0x00001d